Answers are grounded in this paper and cite their sources.
We report our clinical and laboratory experience treating a 50-year-old patient who was critically ill with extensively drug-resistant Acinetobacter baumannii necrotizing pneumonia complicated by empyema in Detroit, Michigan. A precision medicine approach using whole-genome sequencing, susceptibility testing, and synergy analysis guided the selection of rational combination antimicrobial therapy.
No takes yet. Share an insight, caveat, or question.
Holger et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: